---
title: "ENVA: Q2 2026 revenue rose 21.6% and net income jumped 38%, driven by portfolio growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293669982.md"
description: "Revenue grew 21.6% year-over-year in Q2 2026, with net income up 38% to $105.1 million and strong growth in both consumer and small business portfolios. The company expanded funding capacity, maintained robust liquidity, and is progressing toward closing the Grasshopper Bancorp acquisition.Original document: Enova International, Inc. [ENVA] SEC 10-Q Quarterly Report — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T21:16:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293669982.md)
  - [en](https://longbridge.com/en/news/293669982.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293669982.md)
generator: "portal-rs"
---

# ENVA: Q2 2026 revenue rose 21.6% and net income jumped 38%, driven by portfolio growth

Revenue grew 21.6% year-over-year in Q2 2026, with net income up 38% to $105.1 million and strong growth in both consumer and small business portfolios. The company expanded funding capacity, maintained robust liquidity, and is progressing toward closing the Grasshopper Bancorp acquisition.

Original document: Enova International, Inc. \[ENVA\] SEC 10-Q Quarterly Report — Jul. 23 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ENVA.US](https://longbridge.com/en/quote/ENVA.US.md)

## Related News & Research

- [$100 Invested In Enova International 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/298076196.md)
- [Enova’s Earnings Surge Meets a Valuation Test](https://longbridge.com/en/news/297909578.md)
- [The AI doomsday debate intensifies](https://longbridge.com/en/news/298831736.md)
- [Salesforce has held talks to buy Listen Labs, an AI customer research platform, for $2 billion](https://longbridge.com/en/news/298495335.md)
- [NPCE: FDA approval for IGE and AI-driven tools could significantly expand market reach and accelerate growth](https://longbridge.com/en/news/298482113.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**